Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Board/Management Information 2014

Jun 24, 2014

3358_iss_2014-06-24_a4d26d42-27b8-419e-b494-33e876919587.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Announcement No. 7/2014

24 June 2014

Coloplast strengthens Executive Management

Today, the Board of Directors have decided to expand the Executive Management from two to four members as of 1 July 2014.

Kristian Villumsen is appointed Executive Vice President, Chronic Care (EVP, CC) with responsibility for Global Marketing, R&D and sales regions within ostomy - and continence care. Since joining Coloplast in 2008, Kristian has been head of Global Marketing, Europe 11 and most recently Region Emerging Markets. Kristian holds a Master's degree in political science and an MPP.

Allan Rasmussen is appointed Executive Vice President, Global Operations (EVP, GO) with responsibility of Global Operations, Procurement and Quality & Environment. Since joining Coloplast in 1992, Allan has had a number of management assignments within production, sales and procurement. Allan holds a degree as engineer and an MBA.

Anders Lonning-Skovgaard is appointed Chief Financial Officer (CFO) with responsibility for Corporate Finance and Corporate IT. Since joining Coloplast in 2006, Anders has held a commercial management position and most recently been SVP for Corporate IT. Anders holds a financial Master's degree.

The expansion of the Executive Management team aligns with Coloplast's ambitious growth strategy and the new long term financial guidance.

As of 1 July 2014, the Executive Management team will consist of:

CEO - Lars Rasmussen (age 55) EVP, Chronic Care - Kristian Villumsen (age 43) EVP, Global Operations - Allan Rasmussen (age 47) CFO - Anders Lonning-Skovgaard (age 41)

CFO Lene Skole is leaving Coloplast for a position as CEO of the Lundbeck Foundation, as of 1 September 2014.

Today, 24 May 2014 at 13:30 CEST, Coloplast holds a conference call with an expected duration of 30 minutes. Call +45 3271 4607, +44 (0)20 7162 0077 or +1 334 323 6201 to join the conference cal. The reference code is 945971. A webcast will be available at www.coloplast.com shortly after.

Chairman of the board Michael Pram Rasmussen

For further information, please contact

Investors and analysts

Ian S.E. Christensen Vice President, Investor Relations Tel. +45 4911 1800/+45 4911 1301 Email: [email protected]

Nick Fridberg Sr. Investor Relations Manager Tel. +45 4911 1800/+45 4911 1456 Email: [email protected]

Press and the media

Simon Mehl Augustesen Media Relations Manager Tel. 4911 3488 Email: [email protected]

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2014-06 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Our business includes Ostomy Care, Urology Care, Continence Care and Wound and Skin Care. We operate globally and employ more than 8,500 people.